MedBeats
Breaking news and information from the CDC, FDA and medical journals.
The Clinical Effectiveness of Sertraline in Primary Care and the Role of Depression Severity and Duration (PANDA)
Sertraline is unlikely to reduce depressive symptoms within 6 weeks in primary care.
Read MorePrognostic Impact of the 21-Gene Recurrence Score Assay Among Young Women
The RS assay is prognostic among young women with node-negative and limited node-positive breast cancer.
Read MoreAbdominal Adipose Tissue Is Associated With Alterations in Tryptophan-Kynurenine Metabolism
In PWH, increase in abdominal adipose tissue was associated with increased quinolinic-to-kynurenic acid ratio, suggesting activation of proinflammatory pathway of kynurenine metabolism
Read MoreNatural Compound Library Screening Identifies New Molecules for the Treatment of Cardiac Fibrosis and Diastolic Dysfunction
Identified the molecules bufalin and lycorine as drug candidates for therapeutic applications in cardiac fibrosis and diastolic dysfunction.
Read MoreThe Influence of Simulated Sunlight on the Inactivation of Influenza Virus in Aerosols
Results are consistent with epidemiological findings that sunlight levels are inversely correlated with influenza transmission.
Read MoreSystematic Review of Doppler for Detecting Intrapartum Fetal Heart Abnormalities
Studies and program learning are needed to translate improved detection of FHR abnormalities to improved case management in LMICs.
Read MoreInterventions and Operations 5 Years After Bariatric Surgery
Helps to inform procedure-specific decision-making for prospective patients with severe obesity and their physicians.
Read MoreEndoscopic or Surgical Myotomy in Patients with Idiopathic Achalasia
Trials shows gastroesophageal reflux was more common among patients who underwent POEM than among those who underwent LHM.
Read MoreThe Effect of Dulaglutide on Stroke
Long-term dulaglutide use might reduce clinically relevant ischaemic stroke in people with T2D.
Read MoreUse of Professional-Mode Flash Glucose Monitoring, at 3-Month Intervals, in Adults with T2D in GP
Professional-mode flash glucose monitoring in adults with T2D in general practice did not improve the primary outcome of HbA[1c] at 12 months
Read More